Anti-tumor action and clinical application of proteasome inhibitor
Authors:
- 1 June 2008
- journal article
- review article
- Published by Chinese Journal of Cancer Research in Chinese Journal of Cancer Research
- Vol. 20 (2) , 77-84
Abstract
Ubiquitin-proteasome pathway mediates the degradation of cell protein, and cell cycle, gene translation and expression, antigen presentation and inflammatory development. Proteasome inhibitor can inhibit growth and proliferation of tumor cell, induce apoptosis and reverse multipledrug resistance of tumor cell, increase the sensitivity of other chemotherapeutic drugs and radiotherapy, and is a novel class of potent anti-tumor agents.Keywords
This publication has 29 references indexed in Scilit:
- Low dose velcade, thalidomide and dexamethasone (LD-VTD): An effective regimen for relapsed and refractory multiple myeloma patientsLeukemia & Lymphoma, 2006
- PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II studyAnnals of Oncology, 2005
- Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignanciesBlood, 2005
- Severe irreversible bilateral hearing loss after bortezomib (VELCADE®) therapy in a multiple myeloma (MM) patientLeukemia, 2005
- Bortezomib is an efficient agent in plasma cell leukemiasInternational Journal of Cancer, 2004
- Proteasome Inhibition Sensitizes Non–Small-Cell Lung Cancer to Gemcitabine-Induced ApoptosisThe Annals of Thoracic Surgery, 2004
- Phase II Trial of Bortezomib for Patients With Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 2004
- Hyposmotic Stress Induces Cell Growth Arrest via Proteasome Activation and Cyclin/Cyclin-dependent Kinase DegradationJournal of Biological Chemistry, 2002
- Identification of the regulatory region required for ubiquitination of the cyclin kinase inhibitor, p21Biochemical and Biophysical Research Communications, 2002
- Glucose Starvation and Hypoxia Induce Nuclear Accumulation of Proteasome in Cancer CellsBiochemical and Biophysical Research Communications, 1999